A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists ...

TB-500 (a fragment of Thymosin Beta-4) and BPC-157 (Body Protection Compound) are two naturally derived peptide chains that have been the subject of significant academic interest. Each has been ...

Inflammation is a critical component of the immune response that plays a pivotal role in maintaining tissue homeostasis.

Cardiovascular and metabolic health are influenced by the circadian system, which regulates 24-hour rhythms across numerous physiologic processes. Disruptions to circadian rhythmicity can adversely ...

Five routine tests provide limited clinical value, and evidence-based alternatives can better guide diagnosis, risk for ...

The Radioligand Therapy Market is projected to reach US$13 billion by 2030, growing at an estimated rate of ~5%. Key drivers of this growth include the rising incidence of cancers such as prostate ...

Lineage Cell Therapeutics, Inc. (($LCTX)) announced an update on their ongoing clinical study. Study Overview: The DOSED clinical study, ...

In Q1 FY26, cash receipts from customers were A$15k. The net cash used in G&A activities in the quarter was A$578k, compared to A$1.44 million in Q4 FY25. Payments to Related Parties comprises ...

The Australian market recently experienced a dip, with the ASX down 0.3% as investors awaited key CPI data and closely monitored geopolitical developments, such as the US-China diplomatic talks. In ...

Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced interim safety ...